Department of Clinical Laboratory, the Third People's Hospital of Dalian, Dalian, China.
Department of Clinical Laboratory, the Baotou Medical College of Inner Mongolia University of Science and Technology, Inner Mongolia, China.
Yonsei Med J. 2019 Nov;60(11):1093-1102. doi: 10.3349/ymj.2019.60.11.1093.
Staphylococcal enterotoxin B (SEB) has been well-documented to induce liver injury. miRNA-222-3p (miR-222-3p) was implicated in SEB-induced lung injury and several liver injuries. This study aimed to explore the role of miR-222-3p in SEB-induced liver injury.
Expression of miR-222-3p and suppressors of cytokine signaling 1 (SOCS1) was detected using real-time quantitative PCR and western blot. Liver injury was determined by levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and inflammatory cytokines, numbers of infiltrating mononuclear cells using AST/ALT assay kit, enzyme-linked immunosorbent assay (ELISA), and hematoxylin-eosin staining, respectively. Target binding between miR-222-3p and SOCS1 was predicted on targetScan software, and confirmed by luciferase reporter assay.
SEB induced liver injury in D-galactosamine (D-gal)-sensitized mice, as demonstrated by increased serum levels of AST and ALT, elevated release of interferon-gamma (INF-γ), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and IL-2, and promoted infiltrating immune cells into liver. Expression of miR-222-3p was dramatically upregulated, and SOCS1 was downregulated in SEB-induced liver injury both in mice and splenocytes. Moreover, miR-222-3p knockout (KO) mice exhibited alleviated liver injury accompanied with SOCS1 upregulation. Besides, splenocytes under SEB challenge released less INF-γ, TNF-α, IL-6, and IL-2 during miR-222-3p knockdown. Mechanically, SOCS1 was targeted and downregulated by miR-222-3p. Upregulation of SOCS1 attenuated INF-γ, TNF-α, IL-6, and IL-2 release in SEB-induced splenocytes; downregulation of SOCS1 could block the suppressive role of miR-222-3p knockdown in SEB-induced splenocytes.
Inhibition of miR-222-3p relieves SEB-induced liver inflammatory injury by upregulating SOCS1, thereby providing the first evidence of miR-222-3p in SEB-induced liver injury.
葡萄球菌肠毒素 B(SEB)已被充分证明可导致肝损伤。miR-222-3p(miR-222-3p)参与 SEB 诱导的肺损伤和几种肝损伤。本研究旨在探讨 miR-222-3p 在 SEB 诱导的肝损伤中的作用。
实时定量 PCR 和 Western blot 检测 miR-222-3p 和细胞因子信号转导抑制因子 1(SOCS1)的表达。AST/ALT 测定试剂盒、酶联免疫吸附试验(ELISA)和苏木精-伊红染色分别测定血清中天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)和炎症细胞因子水平、浸润单核细胞数量,以确定肝损伤程度。靶标扫描软件预测 miR-222-3p 与 SOCS1 的靶标结合,并通过荧光素酶报告基因检测进行验证。
在半乳糖胺(D-gal)致敏的小鼠中,SEB 诱导肝损伤,表现为血清 AST 和 ALT 水平升高,干扰素-γ(INF-γ)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)和白细胞介素-2(IL-2)释放增加,以及免疫细胞浸润到肝脏。在 SEB 诱导的肝损伤中,miR-222-3p 在小鼠和脾细胞中均显著上调,SOCS1 下调。此外,miR-222-3p 敲除(KO)小鼠肝损伤减轻,SOCS1 上调。此外,在 SEB 刺激下,miR-222-3p 敲低的脾细胞释放的 INF-γ、TNF-α、IL-6 和 IL-2 减少。机制上,SOCS1 是 miR-222-3p 的靶标并被其下调。SOCS1 的上调减弱了 SEB 诱导的脾细胞中 INF-γ、TNF-α、IL-6 和 IL-2 的释放;下调 SOCS1 可阻断 miR-222-3p 敲低在 SEB 诱导的脾细胞中的抑制作用。
抑制 miR-222-3p 通过上调 SOCS1 缓解 SEB 诱导的肝炎症性损伤,为 miR-222-3p 在 SEB 诱导的肝损伤中的作用提供了首个证据。